Ronald J Eby

Title: Innovations in Immunogenic Conjugates by Ronald J Eby

Introduction

Ronald J Eby is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of immunology, particularly in the development of immunogenic conjugates. With a total of 3 patents, his work focuses on enhancing vaccine efficacy against bacterial pathogens.

Latest Patents

Eby's latest patents include innovative immunogenic conjugates derived from streptococcus pneumoniae capsular polymer. One of his key inventions is an immunogenic conjugate that is the reductive amination product of a capsular polymer fragment with at least one reducing group. This conjugate is designed to elicit effective levels of anti-capsular polymer antibodies in humans. The invention also encompasses methods for preparing these conjugates and a vaccine that can induce active immunization against systemic infections in young mammals caused by bacterial pathogens. A preferred embodiment of this invention involves capsular polymer fragments that have aldehyde groups at each end, resulting in a lattice or network structure that provides high levels of anti-capsular polymer antibodies in infants.

Career Highlights

Eby is affiliated with the University of Rochester, where he continues to advance research in immunology. His work has been instrumental in developing vaccines that can significantly improve public health outcomes.

Collaborations

Eby collaborates with Porter W Anderson, contributing to the innovative research environment at the University of Rochester.

Conclusion

Ronald J Eby's contributions to immunogenic conjugates represent a significant advancement in vaccine technology. His innovative approaches have the potential to improve immunization strategies against bacterial infections, particularly in vulnerable populations.